EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights
Related Experiment Video
Updated: Sep 26, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
1Dept. of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. ladanyim@mskcc.org
Abstract:
The EWS-FLI1 fusion resulting from the specific t(11;22)(q24;q12) of Ewing's sarcoma was the first sarcoma gene fusion to be cloned, a decade ago. Moving from the cloning of this oncogenic chimeric transcription factor to the further elucidation of its pathogenetic mechanisms has revealed new complexities in the biology of this tumor which may be relevant to other fusion oncogenes as well. The present review highlights recent advances in three avenues of investigation that are providing new insights into this particular neoplasm and into the biology of EWS-FLI1 and related fusion proteins, namely the identification of various mitogenic targets of this aberrant transcription factor, its possible role as a deregulator of splicing, and the role of the p53 pathway in modulating its oncogenicity.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Non-Canonical Wnt Signaling Pathways
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

